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Abstract
Background: Unintentional non-adherence has been characterized as passively inconsistent medication-taking
behavior (forgetfulness or carelessness). Our objectives were to: (1) study the prevalence and predictors of
unintentional non-adherence; and (2) explore the interrelationship between intentional and unintentional
non-adherence in relation to patients’ medication beliefs.
Methods: We conducted a cross-sectional survey of adults with asthma, hypertension, diabetes, hyperlipidemia,
osteoporosis, or depression from the Harris Interactive Chronic Illness Panel. The analytic sample for this study
included 24,017 adults who self-identified themselves as persistent to prescription medications for their index
disease. They answered three questions on unintentional non-adherence (forgot, ran out, being careless), 11
questions on intentional non-adherence, and three multi-item scales assessing perceived need for medication
(k=10), perceived medication concerns (k=6), and perceived medication affordability (k=4). Logistic regression was
used to model predictors of each unintentional non-adherence behavior. Baron and Kenny’s regression approach
was used to test the mediational effect of unintentional non-adherence on the relationship between medication
beliefs and intentional non-adherence. Bootstrapping was employed to confirm the statistical significance of these
results.
Results: For the index disease, 62% forgot to take a medication, 37% had run out of the medication, and 23% were
careless about taking the medication. Common multivariate predictors (p<.001) of the three behaviors were: (1)
lower perceived need for medications; (2) more medication affordability problems; (3) worse self-rated health; (4)
diabetes or osteoporosis (relative to hypertension); and (5) younger age. Unique statistically-significant predictors of
the three behaviors were: (a) ‘forgot to take medications’ - greater concerns about the index medication and male
gender; (b) ‘run out of medications’ - non-white race, asthma, and higher number of total prescription medications;
(c) ‘being careless’ - greater medication concerns. Mediational tests confirmed the hypothesis that the effect of
medication beliefs (perceived need, concerns, and affordability) on intentional non-adherence is mediated through
unintentional non-adherence.
Conclusions: For our study sample, unintentional non-adherence does not appear to be random and is predicted
by medication beliefs, chronic disease, and sociodemographics. The data suggests that the importance of
unintentional non-adherence may lie in its potential prognostic significance for future intentional non-adherence.
Health care providers may consider routinely inquiring about unintentional non-adherence in order to proactively
address patients’ suboptimal medication beliefs before they choose to discontinue therapy all together.
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Medication adherence refers to the extent of conformity
to treatment recommendations with respect to the tim-
ing, dosage, frequency, and duration of a prescribed
medication [1]. Non-adherence to chronic medications is
an Achilles’ heel of evidence-based medicine and is one
of the major reasons why patients fail to reach their clin-
ical goals, resulting in suboptimal health outcomes [2,3].
In an effort to better understand the underlying causes
of patients’ medication-taking behaviors, researchers
have differentiated between two types of non-adherence.
Intentional non-adherence is an active decision on the
part of patients to forego prescribed therapy [4,5]. Unin-
tentional non-adherence, on the other hand, is a passive
process whereby patients fail to adhere to prescribing
instructions through forgetfulness, carelessness, or cir-
cumstances out of their control (e.g., health literacy)
[6,7]. Patients can, and often do, exhibit both types of
non-adherent behaviors [8-10]. Intentional non-adherence
may be demonstrated through non-fulfillment of a new
prescription or through discontinuation of an existing
medication therapy without the advice of a provider. Ap-
proximately 15% of patients do not fill a new prescription
[11]; of those who do fill a new prescription, roughly 50%
discontinue therapy in the first six months [3,12,13].
Estimates of unintentional non-adherence vary consider-
ably and range from 20% to over 50% [7,8,10,14-23].
Research over the past 20 years has consistently shown
that intentional non-adherence is driven by patient
beliefs about their treatment, disease, and prognosis as
well as their objective experiences with medications [24-
27]. Some early research on unintentional non-adherence
suggested it was more strongly correlated with demo-
graphic characteristics [6,7,28,29] than with medication
knowledge or beliefs. Recent work, however, indicates that
that there may be more to unintentional non-adherence
than pure forgetfulness or carelessness [10,15,20,21,30,31].
Patients reporting intentional versus unintentional non-ad-
herence have been found to be similar to one another in
terms of their adherence-related knowledge and motiv-
ation [31]. Unintentional non-adherence has also been re-
cently linked to perceived need for medications [10,30],
medication concerns [15,19,21], and beliefs about treat-
ment efficacy [20], which suggests that interventions focus-
ing on patients’ medication beliefs may be required to
address both intentional and unintentional non-adherence.
Although recent studies have begun to clear the veil
on unintentional non-adherence, the generalizability of
the evidence to date is limited by small samples in niche
populations. A majority of these results were reported in
samples of about 150 patients or less [9,10,15,20,30], typi-
cally for a single condition [9,10,15,20,31], and usually with
a single-item measure of unintentional non-adherence
[15,20,30,31]. The one study that was conducted in
multiple chronic diseases with somewhat of a larger sam-
ple only targeted Medicare enrollees and excluded unin-
sured patients or those enrolled primarily in private/
employer-sponsored health plans [21]. Finally, although
it has been documented that patients exhibit both
intentional and unintentional non-adherence, no previous
study has explored the interrelationship between unin-
tentional and intentional non-adherence in relation to
patients’ medication beliefs. The current study, conducted
in a large sample of adults with chronic disease, aimed to:
(1) report the prevalence of unintentional non-adherence;
(2) explore whether medication beliefs predict uninten-
tional non-adherence; and (3) explore the interrelationship
between unintentional and intentional non-adherence in
relation to medication beliefs.
Methods
Study population
A cross-sectional survey of U.S. adults with self-reported
chronic disease was conducted using the Harris Inter-
active Chronic Illness Panel (CIP). CIP participants are
recruited through a number of avenues, including postal-
mail invitations, television advertisements, telephone re-
cruitment for under-represented populations, targeted
email solicitations, and text-banner placements on web-
sites (e.g., social-media, news sites, search-engine sites
and community portals). In February and March of 2009,
randomly-selected members of the CIP were sent an e-
mail invitation to participate in the survey. Panel mem-
bers responding to the e-mail invitation were instructed
to read the informed consent form and click on yes if
they agreed to participate. The study was approved by
the George Mason University Institutional Review Board.
Panel members were eligible for participation if they
were aged 40 and older, resided in the U.S., and reported
one of six chronic diseases (hypertension, hyperlipidemia,
diabetes, asthma, osteoporosis, or depression). Only per-
sons age 40 and older were sampled because they bear a
greater burden of chronic disease compared to adults aged
18–39. The six chronic diseases reflect a mix of symp-
tomatic, asymptomatic, and mental-health conditions.
They are some of the most highly prevalent conditions in
the U.S. [32] and are associated with a significant clinical
and economic burden for the U.S. health care system [33].
Requests for survey participation were sent to 204,266
randomly-selected CIP members. Of these invitations,
there were 11,945 invalid e-mail addresses. Of the
192,321 invitations with valid e-mail addresses, 17,121
were ineligible due to age less than 40. Of the 175,200
age-eligible persons with a valid e-mail address, 51,774
completed the screener (29.5% survey contact rate per
standards recommended by The American Association
for Public Opinion Research [34]).
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members’ chronic disease status was reconfirmed and
their medication-taking behavior for the index condition
was solicited. The screener solicited the number of medi-
cations respondents currently took for each disease as
well as the length of time they reported continuously
taking the medication. These items were used to classify
respondents as currently persistent to their medication.
To identify respondents as non-persisters, the survey
asked if, in the last year, they had stopped taking a pre-
scription medication for one of the six conditions with-
out their providers telling them to do so. To identify
respondents as non-fulfillers, the survey asked if, in the
last year, they had received, but did not fill, a new pre-
scription from their provider for one of the six target
conditions. Only subjects who self-identified themselves
as persistent to (i.e., currently on therapy with) prescrip-
tion medications for their index disease form the analytic
sample for this study. The index disease was the disease
for which respondents completed the medication-belief
items. If self-reported persisters reported more than one
of the six target conditions, one was randomly selected
as the index disease. Because non-fulfillers never filled
the index medication, they were not asked questions
about unintentional non-adherence. Self-reported non-
persisters were excluded from the analytic sample be-
cause their complete discontinuation of therapy cannot,
logically, be unintentional.
Survey content
Study participants completed a core set of questions on
demographics and self-reported health status. They
answered three questions on unintentional non-adherence
in reference to the prescription medications for their index
disease: During the past six months: (1) did you ever forget
to take the prescription medication; (2) did you ever run
out of the prescription medication; and (3) were you care-
less at times about taking the prescription medication?
Respondents also answered 11 questions on intentional
non-adherence in reference to their medication-taking be-
havior in the past six months for their index disease. These
questions surveyed the respondents on the following beha-
viors: took less medication than instructed because they
felt better/worse; skipped taking medication because they
felt better/worse; altered dose of medication to suit own
needs; stopped taking medication because they felt better/
worse; skipped doses to make medication last longer; took
smaller doses to make medication last longer; skipped
doses of medication because they did not think it was
helping them; and stopped medication because they did
not think it was helping them. Both sets of measures of
unintentional and intentional non-adherence were adapted
from validated measures published in the peer-review lit-
erature [35-39].
Finally, respondents answered 20 questions assessing
their beliefs about the index medication: perceived need
for the medication (k=10), perceived medication con-
cerns (k=6), and perceived medication affordability
(k=4). As described elsewhere [26], multi-item scales
were created by summing raw items into a scale score
and linearly transforming each sum to a 0–100 metric,
with 100 representing the most favorable belief (highest
perceived need, fewest perceived concerns, fewest afford-
ability issues), 0 the least favorable, and scores in be-
tween representing the percentage of the total possible
score. Each multi-item scale was highly reliable [26].
Included in the 20 items were the three items from
the Adherence Estimator
W, a brief, three-item adherence
screener. One item each from the Adherence Estimator
W
assessed the domains of perceived need for medications,
perceived medication concerns, and perceived medica-
tion affordability [26].
Analysis
Logistic regression was used to assess differences between
age-eligible CIP members with valid e-mail addresses who
did and did not responded to the screener (survey non-
contact bias per standards recommended by The Ameri-
can Association for Public Opinion Research [34]). Inde-
pendent variables were age, gender, race, education,
income, geographic region of residence, and chronic dis-
ease. Prevalence of unintentional and intentional non-
adherence among self-identified persisters was tabulated.
Chi-square tests were used to assess for variation of any
unintentional non-adherence across key variables. Multi-
variate logistic regression models were used to predict
each of the three unintentional non-adherence behaviors
(dichotomized as yes/no) as well as any unintentional
non-adherence behavior using the multi-item scales for
perceived need, perceived concerns, and perceived afford-
ability as independent variables. To assess whether the re-
lationship between medication beliefs and unintentional
non-adherence was linear and monotonic, we divided each
multi-item scale into quartiles and modeled them as
dummy variables. We also modeled unintentional non-
adherence using the Adherence Estimator
W total score (0–
36) and risk levels for non-adherence (low, medium, high)
based on the total score. As described elsewhere [26],
respondents were classified as low risk for non-adherence
if they had a total score of 0, medium risk if they had a
score of 2–7, and high risk for non-adherence if they had a
score of 8 or higher. Covariates in the models included
age, gender, race, education, income, index disease, em-
ployment status, and self-rated health. All analyses were
conducted using Stata SE version 10.
We hypothesized that the effect of medication beliefs
(perceived need, perceived concerns, and perceived afford-
ability) on intentional non-adherence would be mediated
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was hypothesized that medication beliefs would significantly
impact unintentional non-adherence which, in turn, would
significantly influence their intentional non-adherence
(Figure 1).
The most commonly-used method for testing medi-
ation hypotheses is the causal steps approach by Baron
and Kenny [40]. For a variable to be considered a medi-
ator according to this approach, four conditions must be
met [40,41]: (1) the independent variable must be signifi-
cantly associated with the mediator—path a in Figure 1;
(2) the mediator must be significantly associated with the
dependent variable—path b in Figure 1; (3) the inde-
pendent variable must be significantly associated with
the dependent variable—path c in Figure 1; and (4) the
direct effect of the independent variable on the
dependent variable after controlling for the mediator
must be less than the total effect without controlling for
the mediator—path c’ in Figure 1 should have a smaller
coefficient than c. These four conditions were tested
using four linear regression models. For this analysis,
two separate multi-item scales were created for uninten-
tional and intentional non-adherence by summing raw
items (three items for unintentional non-adherence and
11 items for intentional non-adherence) into a scale
score and linearly transforming each sum to a 0–100
metric, with 100 representing the highest level of non-
adherence (positive response for all items), 0 represent-
ing complete adherence (negative response on all items),
and scores in between representing the percentage of the
total possible non-adherence score.
The regression approach proposed by Baron and
Kenny [40] involves an implicit assumption that the esti-
mates of the indirect effect are normally distributed.
There are reasons to suspect that this assumption may
not always hold when mediation is present as indirect
effects are usually positively skewed and kurtotic [42-44].
A nonparametric resampling procedure called bootstrap-
ping has gained popularity in research on mediation [45-
47] because it makes no assumption about the shape of
the sampling distribution of the indirect effect. Simula-
tion research has shown that bootstrapping is one of the
most valid and powerful methods for testing mediation
effects [43,48-52]. With bootstrapping, one draws several
thousand samples from the original data (of equal size to
the original sample), each of which is obtained by ran-
dom sampling with replacement from the original sam-
ple. As recommended by Hayes and others [41,46], we
conducted a bootstrapping procedure with 5,000 sam-
ples. These samples were then used to compute the
mediated effect and its standard error. Finally, the prob-
ability distribution from all of the resampled estimates
was used to calculate bias-corrected confidence intervals
and bootstrap-estimated standard errors of the mediated
effects [43]. If the confidence interval did not include a
zero, then a significant indirect effect was concluded
[41]. Adjustments for multiple comparisons were made
using the Bonferroni correction approach [48].
Results
Survey non-contact bias
A 29.5% survey contact rate was achieved. Compared to
those age-eligible respondents with valid e-mail addresses
who were invited but did not respond to the screener,
those successfully contacted were more likely to be male,
age 50 and older, Caucasian, and of higher income but
were less likely to have asthma or depression (data not
shown). Sociodemographic characteristics (age, gender,
Patient Beliefs 
(Independent variable) 
Intentional Non-Adherence 
(Dependent variable) 
Unintentional Non-Adherence 
(Mediating variable) 
a
c ( c' ) 
b
a   Total effect of patient beliefs on unintentional non-adherence
b   Total effect of unintentional non-adherence on intentional non-adherence
c   Total effect of patient beliefs on intentional non-adherence
c'  Direct effect of patient beliefs on intentional non-adherence (controlling for
     unintentional non-adherence) 
Figure 1 Conceptual Diagram Showing the Mediating Effect of Unintentional Non-Adherence.
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chronic diseases explained only 3.2% of the variance (Cox
and Snell pseudo R-square test) in panel members’ likeli-
hood of completing the screener.
Sample description
Of the respondents, 24,017 subjects (88%) self-identified
themselves as persistent to the prescription medication
for the index disease. Data on these respondents was
included in the current analysis. As shown in Table 1, a
majority of the self-reported persisters were white (95%),
age 60 years and older, and college educated. Two-thirds
reported their health as good, very good, or excellent.
Over 42% reported hypertension as their index disease,
followed by hyperlipidemia (19%), diabetes (13%), osteo-
porosis (13%), asthma (7%), and depression (5%). Overall,
the respondents had a relatively high perceived need for
medications (mean of 81.9), moderate medication con-
cerns (mean of 66.7) and moderate perceived medication
affordability (mean of 61.4).
Prevalence of unintentional and intentional
non-adherence
An overwhelming majority (70%) of the self-reported per-
sisters reported at least one of the three unintentional
non-adherence behaviors in the past six months (Table 2).
Forgetting to take medication (62%) was the most com-
monly-reported behavior followed by running out of medi-
cations (37%) and being careless at times about taking the
medication (23%). Just over one-third of the respondents
reported at least one of the eleven intentional non-
adherence behaviors in the previous six months. Skipping
doses to make medication last longer was the most com-
monly reported intentional non-adherence behavior (18%),
followed by taking smaller doses to make medication last
longer (15%), and altering dose of medication to suit own
needs (14%).
Bivariate associations with any unintentional
non-adherence
Table 3 shows results of bivariate tests for variation in
any unintentional non-adherence across key independent
variables. The proportion of respondents reporting any
unintentional non-adherence was the highest among per-
sons age 40–49 and decreased as age increased. White
respondents were less likely to report any unintentional
non-adherence compared to other races. Compared to
respondents with education greater than college degree,
respondents with a high school education or less were
significantly less likely to report any unintentional non-
adherence. Retired respondents reported unintentional
non-adherence at the lowest rate, while those actively
looking for a job reported unintentional non-adherence
at the highest rate. Compared to respondents with
Table 1 Sample Description (N=24,017)
Variable N %
Age, Mean (SD) 61.3 (9.4)
40–49 2,415 10.1%
50–59 7,899 32.9%
60–64 4,922 20.5%
65–69 4,028 16.8%
70+ 4,753 19.8%
Gender
Male 11,631 48.4%
Female 12,386 51.6%
Education
High school or less 4,211 17.5%
Some college 9,314 38.8%
College degree 4,178 17.4%
> College degree 6,314 26.3%
Income
< 25 K 3,143 14.7%
≥ 25K<50K 5,862 27.4%
≥50K<75K 4,884 22.9%
≥75K<100K 3,252 15.2%
≥100K 4,215 19.7%
Race
White 22,421 94.5%
Black 521 2.2%
Hispanic 176 0.7%
Other 620 2.6%
Health
Fair/Poor 7,934 33.0%
Good 10,028 41.7%
Very good/Excellent 6,055 25.2%
Index Chronic Disease/Medication
Asthma 1,773 7.4%
Diabetes 3,098 12.9%
Hyperlipidemia 4,639 19.3%
Hypertension 10,199 42.5%
Osteoporosis 3,073 12.8%
Depression 1,235 5.1%
Mean SD
Medication Beliefs Scores
a
Perceived need for medications 81.9 14.6
Perceived medication concerns 66.7 21.9
Perceived medication affordability 61.4 30.1
a Multi-item scales were created for medication beliefs scales by summing raw
items into a scale score and linearly transforming each sum to a 0–100 metric,
with 100 representing the most favorable belief (highest perceived need, fewest
perceived concerns, highest perceived affordability), 0 the least favorable, and
scores in between representing the percentage of the total possible score.
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less than $25,000 were significantly more likely to report
any unintentional non-adherence. Reports of unintentional
non-adherence decreased as self-rated health increased.
Respondents with an index medication for depression had
the lowest reports of unintentional non-adherence (63%)
while those taking osteoporosis medications had the high-
est (77%). Compared to the fourth (best) quartile, persons
in the first three quartiles for perceived need, concerns,
and affordability scales had higher reports of any uninten-
tional non-adherence.
Multivariate predictors of unintentional non-adherence
Table 4 presents results for multivariate analyses. Com-
mon multivariate predictors of each of the three uninten-
tional non-adherence behaviors included: lower perceived
need for medications, lower perceived medication afford-
ability, younger age, worse self-rated health, and diabetes
or osteoporosis (relative to hypertension). Unique predic-
tors of ‘forgot to take medications’ were more medication
concerns and male gender. Unique predictors of ‘run out
of medications’ were non-white race and asthma (relative
to hypertension). Unique predictors of ‘being careless’ were
more medication concerns, non-white race, education
greater than college degree, and asthma (relative to
hypertension).
Respondents with less perceived need for medications,
more medication concerns, and less perceived medication
affordability were significantly more likely to report any
unintentional non-adherence. Compared to respondents
in the highest quartile for perceived need for medications,
those in the first three quartiles were 33% to 51% more
likely to report any unintentional non-adherence. Respon-
dents in the lowest quartile for perceived medication af-
fordability scores were 2.32 times more likely than those
in the highest quartile to report any unintentional non-
adherence. Compared to respondents in the highest quar-
tile for perceived concerns, those in the first three quartiles
were 19% to 27% more likely to report any unintentional
non-adherence.
Across the three medication beliefs, perceived medica-
tion need and perceived medication affordability were
stronger predictors of unintentional non-adherence than
perceived medication concerns. Among demographics,
age was the strongest predictor of unintentional non-
adherence. Respondents in the 40–49 years age category
were almost two times more likely to report any uninten-
tional non-adherence compared to those age 70 or older.
The Adherence Estimator
W total score was a signifi-
cant predictor of each of the three unintentional non-ad-
herence behaviors as well as any unintentional non-
adherence. Compared to persons classified as low-risk by
the Adherence Estimator
W those classified as medium
and high risk were significantly more likely to report for-
getting medications (OR=1.32, 1.44, respectively), care-
lessness with medications (OR=1.43, 1.90, respectively),
running out of medications (OR=1.81, 1.90, respect-
ively), and any unintentional non-adherence (OR=1.59,
1.69, respectively).
Mediating effect of unintentional non-adherence
It was hypothesized that the effect of medication beliefs
(perceived need, perceived concerns, and perceived af-
fordability) on intentional non-adherence is mediated
through unintentional non-adherence. The four condi-
tions outlined by Barron and Kenny for a variable to
be considered as a mediating variable were satisfied
(Table 5). These four conditions, demonstrated by paths
a, b, c, and c’ in Figure 1, were tested through four suc-
cessive linear regressions - models 1, 2, 3, and 4, respect-
ively in Table 5. The direct effect of the three medication
beliefs on unintentional non-adherence was significant
(model 1). Compared to persons in the highest quartile
of perceived need, those in quartiles 1, 2, and 3 scored,
on average, 9.2, 7.5, and 5.1 points, respectively, higher
on the unintentional non-adherence scale (with a higher
score indicating a higher level of unintentional non-
adherence).
Table 2 Prevalence of Unintentional and Intentional
Non-adherence (N=24,017)
Unintentional Non-adherence
Items N %
Ever forget to take medication in past six months 14,987 62.4%
Ever run out of medication in past six months 8,861 36.9%
Careless at times about taking medication
in past six months
5,522 23.0%
Reported at least one of the three unintentional
non-adherence behaviors in the past six months
16,832 70.1%
Intentional Non-adherence
Items N %
Skipped doses to make medication last longer 4,265 17.8%
Took smaller doses to make medication last longer 3,616 15.1%
Altered dose of medication to suit own needs 3,448 14.4%
Stopped taking medication because felt worse 2,071 8.6%
Took less medication because felt better 1,922 8.0%
Skipped medication because felt worse 1,862 7.8%
Skipped medication because felt better 1,766 7.4%
Stopped medication because didn’t think
it was helping
1,785 7.4%
Took less medication because felt worse 1,665 6.9%
Stopped taking medication because felt better 1,529 6.4%
Skipped doses because didn’t think medication
was helping
1,466 6.1%
Reported at least one of the eleven intentional
non-adherence behaviors in the past six months
8,235 34.3%
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intentional non-adherence was significant (model 2), as
was the total effect of medication beliefs on intentional
non-adherence (model 3). Respondents with less per-
ceived need for medications, more medication concerns,
and lower perceived medication affordability had signifi-
cantly higher scores on the intentional non-adherence
scale (higher scores indicating greater intentional non-
adherence). Consistent with the Barron and Kenny ap-
proach [40], the coefficients in model 3 were reduced after
controlling for unintentional non-adherence (model 4).
The statistical significance of the mediational relationship
was confirmed using bootstrapping. The bias-corrected
95% confidence intervals for the indirect effect of the three
medication beliefs (perceived need, perceived concerns,
and perceived affordability) were found to exclude zero.
This confirmed the hypothesis that the effect of medication
beliefs on intentional non-adherence is mediated through
unintentional non-adherence.
Discussion
In a sample of 24,017 adults with chronic disease who self-
identified as being medication persisters, 70% reported at
least one instance of unintentional non-adherence, and
34% reported at least one instance of intentional non-
adherence in the past six months. Forgetfulness was the
most common unintentional behavior while skipping
doses to make the medication last longer was the most
common intentional behavior. Our observed prevalence of
unintentional non-adherence is likely higher than that
reported in other studies [7,14-16,22,23,29,53-56] because
of differences in the recall period as well as the wording of
the question (our study asked whether the respondent
“ever” demonstrated a certain behavior in the past six
months, whereas several other studies asked whether the
respondent “sometimes” demonstrated a certain behavior
(which might be interpreted as a regular behavioral
pattern).
Table 3 Reports of Any Unintentional Non-Adherence
across Key Variables (N=24,017)
Any unintentional non-adherence
N (%)
Age
*
40–49 1,909 (79.0%)
50–59 6,029 (76.3%)
60–64 3,524 (71.6%)
65–69 2,629 (65.3%)
70 and up 2,741 (57.7%)
Gender
Male 8,157 (70.1%)
Female 8,675 (70.0%)
Race
*
White 15,618 (69.7%)
Other 1,008 (76.5%)
Education
*
High school or less 2,803 (66.6%)
Some college 6,710 (72.0%)
College degree 2,925 (70.0%)
Greater than college degree 4,394 (70.0%)
Employment Status
*
Looking for a job 522 (78.9%)
Not looking for a job 1,308 (69.3%)
Retired 5,686 (62.8%)
Disabled 413 (74.5%)
Employed 8,903 (75.1%)
Income
*
< 25K 2,308 (73.4%)
≥ 25K<50K 4,125 (70.4%)
≥50K<75K 3,471 (71.1%)
≥75K<100K 2,252 (69.2%)
≥100K 2,948 (69.9%)
Self-Rated Health
*
Poor/fair 5,913 (74.5%)
Good 7,104 (70.8%)
Very Good/Excellent 3,815 (63.0%)
Disease
*
Asthma 1,338 (75.5%)
Diabetes 2,336 (75.4%)
Hyperlipidemia 3,209 (69.2%)
Osteoporosis 2,365 (77.0%)
Depression 783 (63.4%)
Hypertension 6,801 (66.7%)
Perceived Need for Medication
*
Quartile 1 (Worst) 3,159 (75.5%)
Quartile 2 4,960 (74.7%)
Quartile 3 4,322 (70.7%)
Quartile 4 (Best) 4,391 (62.0%)
Table 3 Reports of Any Unintentional Non-Adherence
across Key Variables (N=24,017) (Continued)
Perceived Medication Affordability
*
Quartile 1 (Worst) 4,297 (82.2%)
Quartile 2 3,774 (72.9%)
Quartile 3 5,097 (68.3%)
Quartile 4 (Best) 3,664 (59.6%)
Perceived Medication Concerns
*
Quartile 1 (Worst) 3,247 (77.6%)
Quartile 2 5,077 (73.6%)
Quartile 3 4,346 (70.7%)
Quartile 4 (Best) 4,162 (61.3%)
* Pearson Chi-square statistic for the omnibus test is significant at p=0.01.
Gadkari and McHorney BMC Health Services Research 2012, 12:98 Page 7 of 12
http://www.biomedcentral.com/1472-6963/12/98Table 4 Logistic Regression Models for Multivariate Predictors of Unintentional Non-Adherence (N=24,017)
Forget to Take
Medication
Run Out of
Medication
Careless at Times
Taking Medication
Any unintentional
non-adherence
OR CI OR CI OR CI OR CI
Age
40–49 1.71* 1.52–1.93 2.21* 1.94–2.51 1.47* 1.28–1.68 1.95* 1.71–2.23
50–59 1.57* 1.44–1.72 2.00* 1.81–2.20 1.24* 1.11–1.37 1.78* 1.62–1.95
60–64 1.45* 1.32–1.58 1.61* 1.46–1.78 1.17
† 1.05–1.30 1.53* 1.39–1.68
65–69 1.28* 1.17–1.40 1.29* 1.16–1.43 1.14^ 1.02–1.27 1.31* 1.20–1.44
Female gender .89* .84–.94 .97 .91–1.03 1.04 .97–1.11 .91
† .85–.97
White race .90 .80–1.02 .74* .66–.84 .85^ .75–.96 .88 .77–1.01
Education
High school or less .79* .72–.87 .78* .70–.85 .77* .69–.85 .75* .68–.82
Some college .94 .88–1.01 .93 .86–1.00 .91^ .84–.99 .93 .86–1.00
College degree .93 .86–1.02 .93 .85–1.01 .90^ .82–.99 .93 .85–1.02
Employment status
Looking for a job .90 .76–1.06 1.04 .88–1.23 .95 .79–1.14 .95 .78–1.16
Not looking for a job .74* .67–.83 .67* .60–.75 .75* .67–.85 .68* .61–.77
Retired .78* .73–.84 .67* .62–.72 .75* .69–.81 .72* .67–.78
Disabled .82^ .68–.98 .84 .70–1.01 .86 .70–1.05 .79^ .64–.97
Income
< 25 K .99 .90–1.09 1.74* 1.58–1.94 1.07 .96–1.20 1.21* 1.09–1.35
≥ 25K<50K .98 .90–1.06 1.35* 1.24–1.46 1.06 .97–1.16 1.09^ 1.00–1.18
≥50K<75K 1.05 .97–1.14 1.20* 1.10–1.30 1.03 .94–1.13 1.12^ 1.03–1.22
≥75K<100K .98 .89–1.07 1.05 .95–1.16 1.07 .97–1.19 1.00 .91–1.10
Self-Rated Health
Poor/fair 1.16* 1.07–1.25 1.70* 1.57–1.85 1.60* 1.46–1.76 1.31* 1.21–1.42
Good 1.18* 1.10–1.26 1.34* 1.24–1.45 1.33* 1.22–1.45 1.25* 1.16–1.34
Disease
Asthma .92 .83–1.03 1.36* 1.21–1.52 1.18
† 1.05–1.33 1.18
† 1.04–1.33
Diabetes 1.37* 1.26–1.50 1.23* 1.12–1.34 1.36* 1.24–1.50 1.38* 1.25–1.52
Hyperlipidemia 1.05 .97–1.13 .96 .89–1.04 1.08 .99–1.17 1.06 .98–1.14
Osteoporosis 1.18* 1.08–1.30 1.47* 1.34–1.61 1.30* 1.17–1.43 1.31* 1.19–1.45
Depression .97 .85–1.10 .94 .82–1.09 1.14 .98–1.33 .95 .83–1.08
Perceived Need for Medication
Quartile 1 1.46* 1.33–1.60 1.41* 1.27–1.55 1.91* 1.72–2.13 1.47* 1.32–1.62
Quartile 2 1.46* 1.35–1.57 1.38* 1.26–1.50 1.55* 1.41–1.70 1.51* 1.39–1.64
Quartile 3 1.32* 1.23–1.43 1.22* 1.20–1.32 1.34* 1.22–1.47 1.33* 1.22–1.44
Perceived Medication Affordability
Quartile 1 1.29* 1.18–1.41 4.65* 4.24–5.11 1.34* 1.21–1.48 2.32* 2.10–2.55
Quartile 2 1.21* 1.11–1.31 2.30* 2.10–2.52 1.23* 1.12–1.36 1.42* 1.31–1.55
Quartile 3 1.16* 1.08–1.25 1.55* 1.42–1.69 1.10^ 1.01–1.21 1.23* 1.14–1.32
Perceived Medication Concerns
Quartile 1 1.25* 1.13–1.38 1.06 .95–1.17 1.25* 1.11–1.39 1.27* 1.14–1.41
Quartile 2 1.20* 1.11–1.30 1.01 .93–1.11 1.18
† 1.08–1.31 1.19* 1.09–1.30
Quartile 3 1.20* 1.11–1.30 1.00 .92–1.09 1.14
† 1.03–1.25 1.19* 1.10–1.29
*p<0.001;
† p<0.01; ^ p<0.05.
Reference Categories for each of the variables in the model were as follows: age 70 and up (Age); male (Gender); non-white (Race); greater than college degree
(Education); currently employed (Employment); income>=100K (Income); very good/excellent (Self-rated health); hypertension (Disease); quartile 4 (Perceived
need, Perceived affordability, Perceived concerns).
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http://www.biomedcentral.com/1472-6963/12/98Intentional non-adherence has been described as an ac-
tive process whereby patients choose to deviate from the
prescribed regimen [7]. On the other hand, unintentional
non-adherence has been described as a passive process, as
inadvertent or accidental medication-taking [57,58]. If un-
intentional non-adherence is truly random or inadvertent,
then one would expect it to be weakly related to demo-
graphic characteristics and medication beliefs.
We found a linear and monotonic association between age
and unintentional non-adherence: unintentional non-adher-
ence decreased as age increased, which may possibly be
attributed to multiple competing demands of professional
a n df a m i l yl i f ea m o n gt h o s ei nt h e i r4 0 ’sa n d5 0 ’s. There is
conflicting evidence from past research about the influence
of age on unintentional non-adherence with some studies
reporting no effect [15,20,21,28-30] and others an inverse ef-
fect similar to that reported herein [6,10]. Unlike previous
studies, our large sample size allowed us to explore this rela-
tionship across several age categories. Consistent with some
past research [7], individuals with lower income were more
likely to report running out of medications, perhaps reflect-
ing occasional cost-related medication underuse. Worse self-
rated health was also a consistent predictor of unintentional
non-adherence, which may possibly be related to a greater
burden of overall medication taking across multiple comor-
bidities. Compared to those with hypertension, having osteo-
porosis or diabetes was associated with a higher likelihood of
each of the three unintentional behaviors. A recent system-
atic review also reported that primary non-adherence, or
medication non-fulfillment, was higher in patients with
osteoporosis compared to hypertension [11]. Women may
perceive osteoporosis to be a less serious condition com-
pared to other diseases [59] and often do not perceive them-
selves to be at risk for osteoporosis [59,60], both of which
may make them vulnerable to unintentional non-adherence.
Diabetes is frequently accompanied by several other comor-
bid chronic conditions, thus increasing the pill burden of
such patients and possibly making them more vulnerable to
unintentional non-adherence.
Patient’s medication beliefs, especially perceived need
for medication and perceived medication affordability,
were strong predictors of unintentional non-adherence.
Patients in the lowest quartile of perceived need for
medications were 1.9 times more likely to report being
Table 5 Unintentional Non-Adherence as a Mediator on the Direct Effect of Patient Beliefs on Intentional
Non-Adherence (N=24,017)
Model 1
Direct effect of
patient beliefs on
unintentional
non-adherence
Model 2
Direct effect of
unintentional
non-adherence
on intentional
non-adherence
Model 3
Total effect of
patient beliefs
on intentional
non-adherence
Model 4
Direct effect of patient
beliefs on intentional
non-adherence
controlling for
unintentional
non-adherence
Pathway a in Figure 1 Pathway b in Figure 1 Pathway c in Figure 1 Pathway c’ in Figure 1
DV = unintentional
non-adherence
DV = intentional
non-adherence
DV = intentional
non-adherence
DV = intentional
non-adherence
B (95% CI)
Predictor Variables
Perceived Need
for Prescription
Quartile 1 9.2* (7.8–10.7) 4.1* (3.4–4.9) 2.7* (1.9–3.4)
Quartile 2 7.5* (6.3–8.2) 1.9* (1.3–2.6) 0.8* (0.2–1.4)
Quartile 3 5.1* (3.9–6.2) 0.6 (−0.1–1.2) −0.2 (−0.8–0.4)
Prescription
Affordability
Quartile 1 18.5* (17.2–19.8) 11.9* (11.2–12.6) 9.0* (8.4–9.7)
Quartile 2 10.0* (8.7–11.3) 5.3* (4.6–5.9) 3.7* (3.1–4.4)
Quartile 3 5.1* (3.9–6.2) 1.5* (0.9–2.1) 0.7* (0.1–1.3)
Prescription
Concerns
Quartile 1 4.5* (3.0–6.0) 7.7* (6.9–8.5) 7.0* (6.3–7.8)
Quartile 2 3.3* (2.1–4.6) 2.5* (1.8–3.1) 2.0* (1.3–2.6)
Quartile 3 2.8* (1.6–4.0) 1.1* (0.4–1.7) 0.6* (0.1–1.2)
Unintentional
Non-Adherence
0.2* (0.2–0.2) 0.2* (0.1–0.2)
*p<0.05; DV = Dependent variable for the specific model being tested.
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http://www.biomedcentral.com/1472-6963/12/98careless at times with medications. Patients in the lowest
quartile of perceived medication affordability were 4.65
times more likely to report running out of medications
at times. Other research has also reported medication
beliefs to be associated with unintentional non-adher-
ence [15,30]. Overall, we found no evidence of uninten-
tional non-adherence being random or accidental [21].
This study has several strengths compared to previous
empirical work on unintentional non-adherence. A large,
internet-based panel of adults with chronic disease was
accessed. The obtained sample represents persons aged
40 and older with one of six chronic diseases from all 50
U.S. states. Our sample is by far the largest in which pre-
dictors of unintentional non-adherence has been
assessed. The multi-item scales assessing perceived need
for medications, perceived medication concerns, and per-
ceived medication affordability have been previously
tested and found to be reliable and valid [26]. Unlike
most previous studies, the analyses were conducted in
multiple chronic diseases including both physical and
psychiatric disorders. Finally, the sophisticated boot-
strapping approach was used to test the relationship be-
tween intentional and unintentional non-adherence.
Despite these strengths, several limitations must be taken
in to account when interpreting the results. This study was
conducted over the Internet with 29.5% survey contact rate.
The CIP recruits panel members through multiple avenues
in an attempt to provide a representative sample of the adult,
chronically-ill population and to reach under-represented
and hard-to-reach populations of interest. However, some
biases were observed in the sample. Specifically, compared
to the U.S. adult population, the obtained sample was under-
represented by adults with income less than $25,000 annu-
ally [61], under-represented by adults with a high school
education or less [62], and over-represented by Caucasians
[63]. As a result, generalizability to the broader population
should be made with caution. Because the obtained sample
is under-represented by persons of lower income relative to
the U.S. adult population, it is likely that the observed
effects of income and perceived medication affordability
represent lower-bound estimates. All respondents were self-
identified persisters to prescription medications, and we did
not confirm this based on pharmacy-claims data or other
adherence metrics (such as pill counts). The unintentional
non-adherence items were dichotomous (yes/no); we did
not inquire about the frequency of each unintentional medi-
cation-taking behavior. Finally, this study had a cross-sec-
tional design. Results from this study, especially the
relationship between intentional and unintentional non-ad-
herence, should be confirmed using longitudinal data.
Numerous measures assessing unintentional non-
adherence exist. For example, the four-item Morisky
Scale [35] contains two items on unintentional non-
adherence and the eight-item Morisky Scale [64]
contains three unintentional items. However, an inter-
pretative problem with most measures of unintentional
non-adherence is that they do not reveal the underlying
reasons for forgetfulness or carelessness. The analyses
reported herein suggest that unintentional non-adher-
ence is influenced by the same drivers as intentional
non-adherence—patients’ beliefs about the medications.
While unintentional non-adherence may appear to be a
rather benign behavior, its importance lies in its potential
prognostic significance. Qualitative research has depicted
how patients test or experiment with their medications
[9,65,66]. It is plausible that acts of unintentional non-
adherence may be prescient of future intentional non-
adherence. Our meditational tests support this hypoth-
esis. With occasional episodes of unintentional non-
adherence, patients may be testing a medication’s effective-
ness or gauging symptom status without the medication.
Others have suggested that reports of forgetfulness in taking
medications may be a proxy for reduced motivation [67],
having doubts about the prescribed therapy [68], or having
low perceived need for the medication [29,69]. Our analyses
support these interpretation as all three medication beliefs
scales were significantly associated with reports of forgetful-
ness, carelessness, and any unintentional non-adherence.
Non-persistence most commonly occurs in the first six
months of therapy [70-77]. It is during this initial period
that both unintentional and intentional non-adherence
should be assessed. Because physicians poorly predict
patients’ adherence [78,79], adherence screeners, like the
Adherence Estimator
W [26], might prove useful in identify-
ing nascent, suboptimal medication beliefs that may lead to
forgetfulness, carelessness, and, perhaps eventually, non-
persistence all together.
Conclusions
For our study sample, unintentional non-adherence does
not appear to be random and is predicted by medication
beliefs, chronic disease, and sociodemographics. Our
data suggests that the importance of unintentional non-
adherence may lie in its potential prognostic significance
for future intentional non-adherence. Health care provi-
ders may consider routinely inquiring about uninten-
tional non-adherence in order to proactively address
patients’ suboptimal medication beliefs before they
choose to discontinue therapy all together.
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